Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Stock Information for Absci Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Absci Corporation

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
Absci to Participate in Upcoming Investor Conferences
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.